谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Roflumilast Foam 0.3% for Adolescent and Adult Patients with Seborrheic Dermatitis: A Randomized, Double-Blinded, Vehicle-Controlled, Phase 3 Trial.

Andrew Blauvelt,Zoe D. Draelos,Linda Stein Gold,Javier Alonso-Llamazares,Neal Bhatia,Janet DuBois,Seth B. Forman,Melinda Gooderham,Lawrence Green,Scott T. Guenthner,Adelaide A. Hebert,Edward Lain,Angela Y. Moore,Kim A. Papp,Matthew Zirwas, Saori Kato, Scott Snyder,David Krupa,Patrick Burnett,David R. Berk,David H. Chu

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY（2024）

引用 4|浏览28
关键词
phase 3,phosphodiesterase 4 inhibitor,randomized controlled trial,roflumilast foam 0.3%,seborrheic dermatitis,STRATUM
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要